DIAMEDICA THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.84 USD | -3.73% |
|
-0.35% | 0.00% |
| 23/05 | DiaMedica Therapeutics Inc. Elects Rick Pauls as Director | CI |
| 09/05 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart calendar DiaMedica Therapeutics Inc.
1c8c8ef2aaff440f04bf.czHK075Hi6dhD9jPC6sQDpMmZKwo858flrNhaqiFe9I.NXP6mukzzMk5bK--TuYgZ8VFD9sasNhU2OIjW563L4sne6yJ2xPg9QdVgQ~b977d7c8f445500d25e5ce246afb0b0b
Upcoming events on DiaMedica Therapeutics Inc.
Past events on DiaMedica Therapeutics Inc.
| 29/05/2024 | Craig Hallum Institutional Investor Conference |
| 22/05/2024 07:30 pm | Annual General Meeting |
| 09/05/2024 05:30 pm | Q1 2024 Earnings Call |
| 09/05/2024 02:00 am | Q1 2024 Earnings Release |
| 20/03/2024 05:30 pm | Q4 2023 Earnings Call |
| 20/03/2024 01:45 am | Q4 2023 Earnings Release |
| 13/02/2024 | Oppenheimer Healthcare Life Sciences Conference |
| 07/02/2024 | International Stroke Conference |
| 16/11/2023 | Craig-Hallum Alpha Select Conference |
| 14/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 14/11/2023 02:58 am | Q3 2023 Earnings Release |
| 15/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 15/08/2023 01:43 am | Q2 2023 Earnings Release |
| 28/07/2023 | AAN Summer Conference |
| 31/05/2023 | Craig-Hallum Institutional Investor Conference |
| 17/05/2023 11:30 pm | Annual General Meeting |
| 16/05/2023 05:30 pm | Q1 2023 Earnings Call |
| 16/05/2023 01:58 am | Q1 2023 Earnings Release |
| 29/03/2023 05:30 pm | Q4 2022 Earnings Call |
| 29/03/2023 02:00 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -16,8 -14,5 -15.76% | -13,7 -13,7 0.31% | 0,00 0,00 - | 0,00 0,00 - | -28,8 -28,5 -0.96% | -39,0 |
|
EBIT Million CAD | Released Forecast Spread | -16,9 -15,7 -7.72% | -16,1 -15,3 -5.18% | -17,4 -19,3 9.57% | -19,1 -18,5 -2.95% | -28,9 -28,7 -0.58% | -38,1 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -15,4 -14,7 -5.04% | -15,5 -14,5 -6.67% | -17,3 -18,9 8.31% | -18,6 -18,3 -1.59% | -26,2 -26,7 1.72% | -36,2 |
|
Net income Million CAD | Released Forecast Spread | -15,5 -14,8 -4.94% | -15,5 -14,6 -6.8% | -17,3 -19,2 9.45% | -18,6 -18,4 -1.3% | -26,3 -26,7 1.69% | -36,1 |
|
EPS USD | Released Forecast Spread | -0,89 -0,93 4.64% | -0,78 -0,72 -8.03% | -0,65 -0,73 10.96% | -0,52 -0,52 0% | -0,60 -0,61 0.83% | -0,69 |
| Announcement Date | 23/03/20 | 10/03/21 | 14/03/22 | 28/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -7,43 -6,52 -14.01% | -6,37 -7,10 10.23% | -7,10 -6,33 -12.06% | -7,92 -7,41 -6.95% | -7,87 -7,93 0.78% | -9,31 | -10,7 | -11,4 | -11,5 | -12,9 | ||||
|
EBIT Million CAD | Released Forecast Spread | -4,54 -6,67 31.96% | -4,29 -6,33 32.16% | -4,21 -5,33 21.03% | -5,41 -5,04 -7.44% | -7,45 -5,95 -25.24% | -6,38 -7,00 8.85% | -7,11 -6,51 -9.21% | -7,93 -7,68 -3.29% | -7,88 -8,55 7.8% | -9,03 | -10,3 | -11,0 | -11,5 | -12,9 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -4,49 -6,67 32.64% | -4,28 -6,68 36.02% | -4,11 -5,45 24.58% | -5,10 -4,98 -2.33% | -7,11 -5,81 -22.23% | -6,02 -6,87 12.42% | -6,15 -6,38 3.48% | -6,97 -7,36 5.27% | -7,06 -8,22 14.16% | -8,60 | -9,76 | -10,2 | -11,5 | -12,9 |
|
Net income Million CAD | Released Forecast Spread | -4,50 -6,68 32.61% | -4,29 -6,33 32.28% | -4,12 -5,33 22.77% | -5,11 -4,99 -2.34% | -7,12 -5,81 -22.39% | -6,03 -6,92 12.84% | -6,16 -6,38 3.33% | -7,00 -7,36 4.89% | -7,07 -8,22 14.04% | -8,57 | -9,76 | -10,2 | -11,5 | -12,9 |
|
EPS USD | Released Forecast Spread | -0,13 -0,20 35% | -0,13 -0,18 27.78% | -0,12 -0,15 18.64% | -0,14 -0,14 0% | -0,20 -0,16 -25% | -0,16 -0,18 9.44% | -0,12 -0,13 5.27% | -0,14 -0,14 0% | -0,14 -0,16 10.64% | -0,16 | -0,19 | -0,20 | -0,22 | -0,25 |
| Announcement Date | 04/05/22 | 10/08/22 | 09/11/22 | 28/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 19/03/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for DiaMedica Therapeutics Inc.
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 05:30 pm | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DMAC Stock
- Calendar DiaMedica Therapeutics Inc.
